Inventor · disambiguated record
Sunil Vandse
Also filed as: VANDSE SUNIL
21 granted patents·8 pending applications·196 citations·filing 2007–2022
96Inventor score
Top patents by PatentIndex Score
29 records- 0198US9375478B1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2015·Granted Jun 28, 2016·24 cites·11 claims
- 0297US10010575B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jul 3, 2018·8 cites·19 claims
- 0397US9981006B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 29, 2018·8 cites·19 claims
- 0497US9974827B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 22, 2018·8 cites·18 claims
- 0597US9968649B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 15, 2018·8 cites·17 claims
- 0697US9962422B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 8, 2018·8 cites·17 claims
- 0797US9925233B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·8 cites·24 claims
- 0897US9919026B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 20, 2018·9 cites·14 claims
- 0997US9750785B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Sep 5, 2017·16 cites·11 claims
- 1097US9744209B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Aug 29, 2017·15 cites·13 claims
- 1197US9687526B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·16 cites·20 claims
- 1296US11135265B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Oct 5, 2021·4 cites·16 claims
- 1396US9993520B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jun 12, 2018·6 cites·14 claims
- 1496US9925234B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·6 cites·15 claims
- 1595US11207372B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Dec 28, 2021·3 cites·13 claims
- 1695US9937223B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Apr 10, 2018·6 cites·18 claims
- 1784USD851757SSyringeVERTICE PHARMA LLC·Filed 2018·Granted Jun 18, 2019·24 cites·1 claims
- 1878USD836772SSyringeVertice Pharma·Filed 2018·Granted Dec 25, 2018·19 cites·1 claims
- 1977US2018133285A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2077US2018153955A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2175US12186362B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2021·Granted Jan 7, 2025·0 cites·18 claims
- 2274US2023256048A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 2373US2021077568A1Peptide congeners with polymer excipientsPAR PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 2472US2020188474A1Peptide congeners with polymer excipientsPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2569US2018185438A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2661US2024278247A1Adapter for clinical, medical and laboratory containersVERTICE PHARMA LLC·Filed 2022·Application pending·0 cites
- 2760US11013702B2Midodrine hydrochloride oral solution and uses thereofVERTICE PHARMA LLC·Filed 2018·Granted May 25, 2021·0 cites·16 claims
- 2855US2021322345A1Midodrine hydrochloride oral solution and uses thereofVERTICE PHARMA LLC·Filed 2021·Application pending·0 cites
- 2942US7955622B2Controlled-release galantamine formulationsACTAVIS GROUP PTC HF·Filed 2007·Granted Jun 7, 2011·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Sunil Vandse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →